Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface
نویسندگان
چکیده
Lysyl oxidase (LOX) remodels the tumour microenvironment by cross-linking the extracellular matrix. LOX overexpression is associated with poor cancer outcomes. Here, we find that LOX regulates the epidermal growth factor receptor (EGFR) to drive tumour progression. We show that LOX regulates EGFR by suppressing TGFβ1 signalling through the secreted protease HTRA1. This increases the expression of Matrilin2 (MATN2), an EGF-like domain-containing protein that traps EGFR at the cell surface to facilitate its activation by EGF. We describe a pharmacological inhibitor of LOX, CCT365623, which disrupts EGFR cell surface retention and delays the growth of primary and metastatic tumour cells in vivo. Thus, we show that LOX regulates EGFR cell surface retention to drive tumour progression, and we validate the therapeutic potential of inhibiting this pathway with the small molecule inhibitor CCT365623.
منابع مشابه
Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer
Lysyl oxidase (LOX) and LOX-like (LOXL) enzymes are key players in extracellular matrix deposition and maturation. LOX promote tumour progression and metastasis, but it may also have tumour-inhibitory effects. Here we show that orthotopic implantation of rat prostate AT-1 tumour cells increased LOX and LOXLs mRNA expressions in the tumour and in the surrounding non-malignant prostate tissue. In...
متن کاملDeregulation of FoxM1b leads to tumour metastasis
The forkhead box M1b (FoxM1b) transcription factor is over-expressed in human cancers, and its expression often correlates with poor prognosis. Previously, using conditional knockout strains, we showed that FoxM1b is essential for hepatocellular carcinoma (HCC) development. However, over-expression of FoxM1b had only marginal effects on HCC progression. Here we investigated the effect of FoxM1b...
متن کاملSynthesis of a Biologically Active Tethered Growth Factor Surface and Comparison with Soluble Delivery
Major impediments to the clinical use of growth factors, polypeptide signaling molecules that promote or inhibit cell growth, are their rapid diffusion away from targeted in vivo sites, internalization by cells, and subsequent down regulation of growth factor receptors. In an effort to overcome these limitations, a model biomaterial surface was developed consisting of a glass slide with epiderm...
متن کاملCALL FOR PAPERS Physiology and GI Cancer Lysyl oxidase in colorectal cancer
Cox TR, Erler JT. Lysyl oxidase in colorectal cancer. Am J Physiol Gastrointest Liver Physiol 305: G659–G666, 2013. First published September 5, 2013; doi:10.1152/ajpgi.00425.2012.—Colorectal cancer is the third most prevalent form of cancer worldwide and fourth-leading cause of cancer-related mortality, leading to 600,000 deaths annually, predominantly affecting the developed world. Lysyl oxid...
متن کاملLysyl oxidase in colorectal cancer.
Colorectal cancer is the third most prevalent form of cancer worldwide and fourth-leading cause of cancer-related mortality, leading to ~600,000 deaths annually, predominantly affecting the developed world. Lysyl oxidase is a secreted, extracellular matrix-modifying enzyme previously suggested to act as a tumor suppressor in colorectal cancer. However, emerging evidence has rapidly implicated l...
متن کامل